NASDAQ · JAZZ
Jazz Pharmaceuticals plc
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for JAZZ: Nov 02, 2026
Jazz Pharmaceuticals plc Common Stock (Ireland) is expected to report earnings on 11/02/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $-5.18. The reported EPS for the same quarter last year was $6.99.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-5.18 | $-4.86 | $-5.64 | 4 |
| Dec 2026 | $5.95 | $7.76 | $5.28 | 6 |
| Mar 2027 | $4.96 | $5.61 | $4.30 | 2 |
| Jun 2027 | $5.43 | $5.44 | $5.41 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · Zacks · Fintel · RTTNews- The Motley Fool · Oct 27, 4:29 PM EDTWhere Will Jazz Pharmaceuticals Be in 5 Years? Oncology Is Becoming Its Growth EngineJazz Pharmaceuticals’ financial results are improving.
- Zacks · Oct 27, 9:00 AM EDTUltragenyx (RARE) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseUltragenyx (RARE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Fintel · Oct 26, 4:51 PM EDTJazz Pharmaceuticals plc Estimates $755 Million Q3 Financial Impact from Actio Biosciences AcquisitionJazz Pharmaceuticals plc announced that its GAAP and non-GAAP financial results for the third quarter of 2026 are estimated to include a pre-tax charge of approximately $755 million of acquired in-process research and development expense. This charge is associated with the compan
- Zacks · Oct 26, 9:00 AM EDTAnalysts Estimate Jazz Pharmaceuticals (JAZZ) to Report a Decline in Earnings: What to Look Out forJazz (JAZZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- RTTNews · Oct 23, 11:07 AM EDTJazz Pharmaceuticals Reports Positive Phase 3 Results For Ziihera Combination(RTTNews) – Friday, Jazz Pharmaceuticals plc (JAZZ) announced updated overall survival results from the Phase 3 HERIZON-GEA-01 trial evaluating Ziihera in combination with chemotherapy, with or without Tevimbra for the treatment of adults with HER2-positive locally advanced or me
- Barchart · Oct 21, 2:24 PM EDTStocks Finish Mostly Higher on Earnings OptimismThe S&P 500 Index ($SPX ) (SPY ) closed up by +0.38% on Tuesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +1.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.13%. December E-mini S&P futures (ESZ26 ) rose +0.33%, and December E-mini…
- Zacks · Oct 21, 10:00 AM EDTWill Auvelity Continue to Aid Axsome's Top-Line Growth in Q3?AXSM's Auvelity sales surged 54.2% to $333 million in the first half of 2026. New indications could further expand its growth potential.
- Barchart · Oct 20, 6:45 PM EDTStocks Pressured by Tech Stock Weakness and Higher Crude Oil PricesThe S&P 500 Index ($SPX ) (SPY ) is down by -0.15% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.82%. December E-mini S&P futures (ESZ26 ) are down -0.10%, and December E-mini…
- Barchart · Oct 20, 6:14 PM EDTStocks Rebound on Strong Earnings and Lower Bond YieldsThe S&P 500 Index ($SPX ) (SPY ) is up by +0.60% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.12%. December E-mini S&P futures (ESZ26 ) are up +0.60%, and December E-mini…
- Barchart · Oct 16, 1:24 PM EDTStocks Settle Mixed as Broader Market Recovers from Chip Stock RoutThe S&P 500 Index ($SPX ) (SPY ) closed up by +0.33% on Thursday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +1.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.05%. December E-mini S&P futures (ESZ26 ) rose +0.28%, and December E-mini…
- Zacks · Oct 16, 8:17 AM EDTIs JAZZ Stock Still a Smart Way to Play Medical Cannabis?Jazz Pharmaceuticals offers a differentiated medical cannabis play, with Epidiolex sales growth and a diversified portfolio offset by pipeline setbacks and earnings pressures.
- Zacks · Oct 16, 7:12 AM EDTHRMY Stock Gains 27.6% in Six Months: Is There More Room for Growth?Harmony Biosciences gains 27.6% in six months as Wakix sales surge and pipeline advances, with new formulations and clinical milestones offering further growth opportunities.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Jazz Pharmaceuticals plc from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.